BioSpace News Archive

Cybin Inc. today announced that it has partnered with Clinilabs Drug Development Corporation to carry out the Company’s Phase 1/2a clinical trial of CYB003, a proprietary deuterated psilocybin analog.

Tvardi Therapeutics, Inc. today announced that its lead product, TTI-101, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC).

Spending on medicines in the United States, at estimated net manufacturer prices, reached $407 billion in 2021, up 12% over 2020, as COVID-19 vaccines and therapeutics became widely available and added $29 billion in related spending.

Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2022 financial results will be released on Thursday, May 5, 2022, after the close of the stock market.

Astria Therapeutics, Inc. today announced that it will share new preclinical data for STAR-0215 in a presentation titled “Development of STAR-0215: An Engineered IgG1 Monoclonal Antibody Targeting Plasma Kallikrein for the Prevention of HAE” at the 2022 Fc Receptor and IgG Targeted Therapies Conference which takes place April 26-28 in Boston, Massachusetts.

NeoSpectra by Si-Ware, the creator of NeoSpectra material analysis solutions built on single-chip FT-NIR spectrometers, announced a partnership with AB Vista’s Aunir, a global leader in the development and supply of near infrared reflectance spectroscopy calibrations.

Health Canada Approves 3rd Generation Clarius Wireless Ultrasound Scanners that Connect with Apple and Android Devices.

VistaGen Therapeutics, Inc. announced that researchers will present preclinical data supporting the differentiated mechanism of action (MOA) for VistaGen’s lead product candidate, PH94B, at two upcoming major scientific congresses.

Artivion, Inc announced today that first quarter 2022 financial results will be released on Thursday, May 5, 2022 after the market closes.

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a corporate and financial update for the first quarter of 2022 on Wednesday, May 4, 2022 at 8:30 a.m. ET.